Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agatha Stegemann

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Experimental Dermatology|January 18, 2019
Tropisetron via α7 nicotinic acetylcholine receptor suppresses tumor necrosis factor-α-mediated cell responses of human keratinocytesAgatha Stegemann, Markus Böhm
Experimental Dermatology|April 5, 2014
Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skinMarkus Böhm, Agatha Stegemann
Experimental Dermatology|August 12, 2020
Targeting the α7 nicotinic acetylcholine receptor-A novel road towards the future treatment of skin diseasesAgatha Stegemann, Markus Böhm
Experimental Dermatology|September 30, 2016
The α7 nicotinic acetylcholine receptor agonist tropisetron counteracts ultraviolet A-mediated oxidative stress in human dermal fibroblastsAgatha Stegemann, Markus Böhm
Pigment Cell & Melanoma Research|December 15, 2019
Fast oxidation of α-melanocyte-stimulating hormone and derived peptides under laboratory conditions causes irreproducible results-Insights from studies of prolylcarboxypeptidase in human cell typesMalte Bayer, Nino Tsiskarishvili, Agatha Stegemann, et al.
Neuroendocrinology|June 13, 2021
Expression of the α7 Nicotinic Acetylcholine Receptor Is Critically Required for the Antifibrotic Effect of PHA-543613 on Skin FibrosisAgatha Stegemann, Verena Raker, Adriana Del Rey, et al.
The Journal of Investigative Dermatology|April 27, 2020
The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin DisordersAgatha Stegemann, Damian Flis, Wieslaw Ziolkowski, et al.
Endocrine Reviews|February 25, 2025
Endocrine Controls of Skin AgingMarkus Böhm, Agatha Stegemann, Ralf Paus, et al.
Acta Dermato-Venereologica|May 26, 2020
Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human MelanomaCarsten Weishaupt, Arianna Mastrofrancesco, Dieter Metze, et al.
Experimental Dermatology|June 17, 2016
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosisVerena K Raker, Kim Y Ook, Jessica Haub, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Experimental Dermatology|January 18, 2019
Tropisetron via α7 nicotinic acetylcholine receptor suppresses tumor necrosis factor-α-mediated cell responses of human keratinocytesAgatha Stegemann, Markus Böhm
Experimental Dermatology|April 5, 2014
Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skinMarkus Böhm, Agatha Stegemann
Experimental Dermatology|August 12, 2020
Targeting the α7 nicotinic acetylcholine receptor-A novel road towards the future treatment of skin diseasesAgatha Stegemann, Markus Böhm
Experimental Dermatology|September 30, 2016
The α7 nicotinic acetylcholine receptor agonist tropisetron counteracts ultraviolet A-mediated oxidative stress in human dermal fibroblastsAgatha Stegemann, Markus Böhm
Pigment Cell & Melanoma Research|December 15, 2019
Fast oxidation of α-melanocyte-stimulating hormone and derived peptides under laboratory conditions causes irreproducible results-Insights from studies of prolylcarboxypeptidase in human cell typesMalte Bayer, Nino Tsiskarishvili, Agatha Stegemann, et al.
Neuroendocrinology|June 13, 2021
Expression of the α7 Nicotinic Acetylcholine Receptor Is Critically Required for the Antifibrotic Effect of PHA-543613 on Skin FibrosisAgatha Stegemann, Verena Raker, Adriana Del Rey, et al.
The Journal of Investigative Dermatology|April 27, 2020
The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin DisordersAgatha Stegemann, Damian Flis, Wieslaw Ziolkowski, et al.
Endocrine Reviews|February 25, 2025
Endocrine Controls of Skin AgingMarkus Böhm, Agatha Stegemann, Ralf Paus, et al.
Acta Dermato-Venereologica|May 26, 2020
Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human MelanomaCarsten Weishaupt, Arianna Mastrofrancesco, Dieter Metze, et al.
Experimental Dermatology|June 17, 2016
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosisVerena K Raker, Kim Y Ook, Jessica Haub, et al.
Pageof 2